ESR1 and breast cancer: This molecular subtype is characterized by a null or minimal expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 and is usually associated with poorer prognosis and higher recurrence rates compared to other molecular subtypes of breast cancer (BC) [1,2].